GPLC (Glycine Propionyl-L-Carnitine).
Nitric oxide booster carnitine. The pre-workout form. Delivers carnitine with a propionyl group attached, supporting blood flow to working muscle while the carnitine backbone carries fatty acids into mitochondria for energy.
Reviewed March 2026
- Category
- Amino acid
- Also filed under
- Nitric oxidePerformancePumps
What GPLC (Glycine Propionyl-L-Carnitine) is, and what it does.
- Does it work
- Suits lifters and cyclists who want a stimulant-free ingredient before a session. People whose interest is the carnitine backbone alone get that from plain carnitine too.
- How much to take
- Start with 1 to 4.5 grams a day, the maintenance band, usually taken before a session. Amounts used in research are a study condition, not a daily target.
- Time to feel it
- Blood flow and pump effects have been reported within about an hour of a pre-training serving. The tissue carnitine pool itself fills slowly, over weeks of daily use.
- The first dose
- Taken an hour before training, some people notice a fuller pump and easier repeat efforts. Away from the gym day one is quiet while tissue carnitine starts to build.
- With regular use
- Tissue carnitine fills over weeks of daily use. Across a training block what people report is easier repeat efforts rather than one dramatic change.
- How well tolerated
- Well tolerated at these amounts, with mild stomach upset the usual report. Check with your doctor first if you're pregnant, breastfeeding or taking prescribed medicines.
- How it feels
- No stimulation at all. What people describe is a warmer, fuller working muscle and slightly easier repeat sets, not a rush.
- The overlooked benefit
- The propionyl group becomes succinyl-CoA and tops up citric acid cycle intermediates, which is chemistry plain carnitine does not bring with it.
1 to 4.5g a day is where GPLC (Glycine Propionyl-L-Carnitine) works.
Source: Inagawa 2006 + Bannai 2012 sleep studies
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 12 human trials with 60% consistency.
- nitric oxide markers and blood flowRandomised trial
- peak power across repeated sprintsRandomised trial
- limb circulation and walking capacityRandomised trial
- fatty acid transport into mitochondriaNarrative review
Questions people ask about GPLC (Glycine Propionyl-L-Carnitine).
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Should I take it on an empty stomach?
- Most amino acids absorb better on an empty stomach since they don't compete with food proteins for absorption. 30 minutes before meals is ideal.
- Can I get enough from protein?
- If you eat enough protein (0.8-1g per pound bodyweight), you probably get enough aminos. Supplementing specific ones only makes sense for targeted goals.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
GPLC raises circulating nitrite and endothelial nitric oxide synthase activity, and arginine is the amino acid substrate that enzyme converts into nitric oxide. Raising enzyme activity without the substrate limits how much nitric oxide is made.
Citrulline escapes first-pass liver arginase and is converted to arginine in the kidney, so it raises plasma arginine more reliably than arginine itself. That feeds the same nitric oxide synthase step GPLC acts on.
Dietary nitrate is reduced to nitrite by oral bacteria and then to nitric oxide in low oxygen tissue, a route independent of nitric oxide synthase. Pairing it with GPLC covers the enzymatic and the nitrate-nitrite routes at once.
Two of the four steps of endogenous carnitine synthesis use ascorbate-dependent dioxygenases, so vitamin C status sets the body's own carnitine output. It also protects tetrahydrobiopterin, the cofactor that keeps nitric oxide synthase coupled.
The hydroxylase enzymes in carnitine biosynthesis are iron-dependent, so iron status governs how much carnitine the body makes from lysine and methionine. Iron is also needed for the heme groups in the electron transport chain that oxidises the fatty acids carnitine delivers.
Carnitine is built from a protein-bound lysine residue whose side chain is trimethylated and then hydroxylated. Lysine is the carbon skeleton the whole pathway starts from.
Methionine becomes S-adenosylmethionine, which donates the three methyl groups that convert a lysine residue into trimethyllysine. Without that methyl supply the carnitine pathway cannot begin.
Pantothenic acid becomes coenzyme A, and carnitine works by swapping acyl groups with CoA at the mitochondrial membrane through CPT1 and CPT2. Low CoA limits the shuttle no matter how much carnitine is present.
Carnitine delivers fatty acids into the mitochondrion for beta-oxidation, and the electron-transferring flavoprotein hands those electrons to coenzyme Q. CoQ10 is the acceptor immediately downstream of the step GPLC feeds.
Acyl-CoA dehydrogenase and the electron-transferring flavoprotein both use FAD made from riboflavin. They act on the fatty acids carnitine has just delivered across the membrane.
Lipoic acid is the cofactor of pyruvate and alpha-ketoglutarate dehydrogenase and it regenerates glutathione and ascorbate inside the mitochondrion. Pairing it with a carnitine ester supports both fuel entry and the redox state of the compartment.
Creatine phosphate buffers ATP over the first seconds of effort while the carnitine shuttle feeds sustained oxidative output. The two energy systems operate on different timescales.
Two steps of each beta-oxidation cycle and the entire Krebs cycle require NAD+ made from niacin. It is the electron acceptor for the fatty acid flux carnitine enables.
Ribose is the rate-limiting sugar for rebuilding the adenine nucleotide pool after heavy effort, while the carnitine shuttle governs the fuel entering that pool. One supplies the carrier molecule, the other the fuel.
The propionyl group released from this molecule becomes propionyl-CoA, and the enzyme that carries it forward, propionyl-CoA carboxylase, is biotin dependent. Without adequate biotin that carboxylation step is the bottleneck on the whole anaplerotic route into the citric acid cycle. This is enzymology rather than a tested combination.
After carboxylation, methylmalonyl-CoA is rearranged into succinyl-CoA by methylmalonyl-CoA mutase, which needs adenosylcobalamin. That is the step that lets the propionyl portion top up citric acid cycle intermediates. B12 status therefore sits directly on the pathway this ingredient is formulated around.
Both are carried across cell membranes by the OCTN2 organic cation transporter, so a large dose of one occupies capacity for the other. Taken together they also add to the same body carnitine pool, meaning the doses should be counted as one total rather than two separate ones. Which ester is presented changes what acyl group arrives, not the transporter used.
Acetyl-L-carnitine and the propionyl ester compete for the same OCTN2 transporter and hydrolyse to the same free carnitine backbone. They differ in the acyl group delivered: acetyl feeds directly into the citric acid cycle as acetyl-CoA, propionyl enters at succinyl-CoA. Stacking both raises total carnitine intake without adding a new mechanism.
Glycine is not an add-on here; it is the counter-ion built into the molecule, which is what the G in the name refers to. Any separate glycine supplement therefore adds to an intake that already exists in the product. Glycine has its own roles as a substrate for glutathione and creatine synthesis and as an inhibitory neurotransmitter.
Carnitine and choline are both converted by gut bacteria to trimethylamine, which the liver oxidises to trimethylamine N-oxide. Taking both raises the substrate load for that microbial step. TMAO is a circulating marker whose interpretation is still debated, and it is a marker rather than an outcome.
Caffeine and this carnitine ester share the same pre-workout formulation slot, one as the stimulant and one for its nitric-oxide positioning. The mechanisms do not overlap and no study of the pairing is cited here. This is how the category is built rather than a demonstrated interaction.
Beta-alanine works over weeks by raising muscle carnosine, while the carnitine ester is dosed acutely, so the two operate on different timescales. They appear in the same blends because they target the same training context. Nothing measured describes them together.
HMB is a leucine metabolite used around resistance training and shares shelf space with carnitine esters. There is no shared pathway between the two beyond both touching muscle energy and protein handling in general terms. The pairing is commercial convention.
Carnitine synthesis consumes methyl groups through the methylation of lysine residues, and betaine is a methyl donor feeding the same economy through homocysteine remethylation. Supplying preformed carnitine reduces the demand rather than adding to it. The relationship is on methyl-group budgeting, not on a joint performance effect.
Taurine is a common companion in endurance and energy formulas, where it is included for cell volume and calcium handling roles rather than for fatty acid transport. It does not share the carnitine transporter or the acyl-CoA route. The combination has not been studied here.
Nothing specific on file for GPLC (Glycine Propionyl-L-Carnitine). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What GPLC (Glycine Propionyl-L-Carnitine) actually does.
The molecule is L-carnitine esterified with a propionyl group and supplied as a glycine salt, so it delivers three distinct pieces: the carnitine backbone, a propionyl group and glycine.
Free carnitine is the shuttle that carries long-chain fatty acids across the inner mitochondrial membrane, using carnitine palmitoyltransferase 1, the translocase and carnitine palmitoyltransferase 2.
The propionyl group is handled as propionyl-CoA, carboxylated by biotin-dependent propionyl-CoA carboxylase and rearranged by B12-dependent methylmalonyl-CoA mutase into succinyl-CoA, which tops up citric acid cycle intermediates.
Carnitine and its esters cross membranes on the OCTN2 transporter, which is sodium dependent and saturable, so absorption efficiency falls as the oral dose rises.
Where GPLC (Glycine Propionyl-L-Carnitine) comes from.
It starts with carnitine, made either by bacteria in a fermenter or in a chemical plant. A small propionyl piece is attached to it, glycine is paired on to make a stable salt, and the powder is dried and packed with a desiccant because it soaks up moisture from the air.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
The starting material is L-carnitine, produced either by microbial fermentation or by chemical synthesis with a resolution step, since only the L enantiomer is biologically active.
A propionyl group is esterified onto the hydroxyl of L-carnitine, typically using propionyl chloride or propionic anhydride under acid conditions, giving propionyl-L-carnitine.
Glycine is combined with the propionyl ester to form the glycine salt that gives the ingredient its name, alongside the hydrochloride counter-ion.
The product is crystallised and dried under vacuum, with residual solvent and unreacted acylating agent controlled by specification testing.
Batches are checked for L-carnitine identity and D-isomer content as well as total assay, because the D form is not the active configuration.
The dried salt is milled, blended with flow aids where needed, and packed with desiccant because the material takes up water readily.
Labels usually do not say whether the underlying L-carnitine came from fermentation or chemical synthesis, and rarely state the D-isomer specification.
Getting GPLC (Glycine Propionyl-L-Carnitine) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Four weeks of glycine propionyl-L-carnitine in trained men raised peak power during repeated sprint testing, with no detectable change in the aerobic performance measures taken.Randomised trial. Smith et al., 2008 (International journal of sport nutrition and exercise metabolism). PMID 18272931 ↗
- Glycine propionyl-L-carnitine raised resting blood nitrate and nitrite, a marker of nitric oxide availability, and lowered a marker of lipid peroxidation in healthy adults; these are markers, not measured outcomes.Randomised trial. Bloomer et al., 2009 (International journal for vitamin and nutrition research). PMID 20209464 ↗
- Longer-term glycine propionyl-L-carnitine did not improve repeated anaerobic sprint performance in the participants studied, and some power measures sat below placebo.Randomised trial. Jacobs et al., 2010 (Journal of the International Society of Sports Nutrition). PMID 20979659 ↗
- Glycine propionyl-L-carnitine taken before forearm blood-flow restriction and release did not produce a detectable reduction in the oxidative stress markers measured afterwards, which is a failure to detect a difference rather than proof of none.Randomised trial. Bloomer et al., 2010 (International journal for vitamin and nutrition research). PMID 20533241 ↗
- In rats given a chemical liver challenge, glycine propionyl-L-carnitine reduced markers of oxidative and inflammatory stress in liver tissue; these are tissue markers in animals, not human outcomes.Animal study. Ganai et al., 2014 (Chemico-Biological Interactions). PMID 24565947 ↗
- The authors measured oxidative stress markers after aerobic and anaerobic power testing and report that training status and carnitine supplementation influenced those markers; the endpoints are biochemical markers rather than performance outcomes.Randomised trial. Bloomer et al., 2009 (Research in Sports Medicine). PMID 19266389 ↗
- The authors review glycine and N-acetylcysteine supplementation with and without exercise for measures of functional ageing, and note where the supporting studies are thin.Narrative review. Wang et al., 2026 (Frontiers in Nutrition). PMID 42232577 ↗
These are the studies our verdict leans on, chosen from the 16 we read for GPLC (Glycine Propionyl-L-Carnitine). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.